Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schopohl

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Der Internist|October 14, 2017
[Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities]S Petersenn, M Christ-Crain, M Droste, et al.
European Journal of Endocrinology|January 30, 2014
Food intake regulating hormones in adult craniopharyngioma patientsJ Roemmler-Zehrer, V Geigenberger, S Störmann, et al.
Pituitary|February 5, 2010
Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care populationC Dimopoulou, C Sievers, H U Wittchen, et al.
Clinical Endocrinology|June 1, 1991
Plasma growth hormone (GH)-releasing hormone levels in patients with lung carcinomaJ Schopohl, M Losa, C Frey, et al.
European Journal of Endocrinology|August 14, 2014
Clinical characteristics of pain in patients with pituitary adenomasC Dimopoulou, A P Athanasoulia, E Hanisch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 19, 2013
Automatic face classification of Cushing's syndrome in women - a novel screening approachR P Kosilek, J Schopohl, M Grunke, et al.
Endocrine|June 10, 2017
Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trialS Petersenn, L R Salgado, J Schopohl, et al.
Clinical Endocrinology|May 28, 2004
One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide AutogelPh Caron, M Bex, D R Cullen, et al.
Pituitary|October 7, 2008
Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological studyC Sievers, P G Sämann, T Dose, et al.
Journal of Endocrinological Investigation|May 10, 2020
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III studyA Lacroix, M D Bronstein, J Schopohl, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Der Internist|October 14, 2017
[Diagnostics and treatment of acromegaly : Necessity for targeted monitoring of comorbidities]S Petersenn, M Christ-Crain, M Droste, et al.
European Journal of Endocrinology|January 30, 2014
Food intake regulating hormones in adult craniopharyngioma patientsJ Roemmler-Zehrer, V Geigenberger, S Störmann, et al.
Pituitary|February 5, 2010
Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care populationC Dimopoulou, C Sievers, H U Wittchen, et al.
Clinical Endocrinology|June 1, 1991
Plasma growth hormone (GH)-releasing hormone levels in patients with lung carcinomaJ Schopohl, M Losa, C Frey, et al.
European Journal of Endocrinology|August 14, 2014
Clinical characteristics of pain in patients with pituitary adenomasC Dimopoulou, A P Athanasoulia, E Hanisch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 19, 2013
Automatic face classification of Cushing's syndrome in women - a novel screening approachR P Kosilek, J Schopohl, M Grunke, et al.
Endocrine|June 10, 2017
Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trialS Petersenn, L R Salgado, J Schopohl, et al.
Clinical Endocrinology|May 28, 2004
One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide AutogelPh Caron, M Bex, D R Cullen, et al.
Pituitary|October 7, 2008
Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological studyC Sievers, P G Sämann, T Dose, et al.
Journal of Endocrinological Investigation|May 10, 2020
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III studyA Lacroix, M D Bronstein, J Schopohl, et al.
Pageof 9